A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual ...
These non-HLA-A*02 patients are enrolled in the open label arm, where the immune or clinical response can be assessed as a group or by each HLA-A type, including double HLA-A types, providing the ...
The human leukocyte antigen (HLA) molecules are proteins expressed on the cell membrane that can activate circulating immune cells, T cells specifically, for targeted cell killing. Alternatively, ...
Caribou Biosciences, Inc. experienced a 45% share price decline after presenting puzzling results for their product candidate CB-010 in a Phase 1 clinical trial. CB-010 showed limited efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results